Subsequent partial correlation analysis revealed a positive correlation between higher NTN‐1 levels and increased severity of motor symptoms (H‐Y stages and UPDRS scores), depression (HAMD scores), and cognitive function (MMSE and MoCA scores) in PD patients. Here, NTN1 is linked to major depressive disorder.